Navigation Links
Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
Date:11/5/2007

,790 965,021 128,793

Other revenue 72 1,018 136 2,718 25,605 3,417

Total revenue 223,840 323,373 43,158 695,508 990,626 132,210

Cost of materials

and production (46,979) (59,042) (7,880) (146,163)(170,009)(22,690)

Gross profit 176,861 264,331 35,278 549,345 820,617 109,520

Operating expenses:

Research and

development expenses (6,954) (19,290) (2,574) (23,196) (52,381) (6,991)

Sales, marketing

and distribution

expenses (103,558)(146,573)(19,562) (318,807)(441,722)(58,953)

General and

administrative

expenses (22,136) (38,227) (5,102) (71,467)(115,283)(15,386)

Income from

operations 44,213 60,241 8,040 135,875 211,231 28,190

Interest income 204 8,503 1,135 617 15,424 2,059

Interest expense (3,561) (21) (3) (8,010) (5,811) (775)

Other income -- 5,494 733 -- 5,494 733

Income before income

tax expense

and minority

interests 40,856 74,217 9,905 128,482 226,338 30,207

Income tax

credit/(expense) 1,439 273 37 (13,861) 2,819 376

Income before

minority interests 42,295 74,490 9,942 114,621 229,157 30,583

Minority interests -- (1,370) (183) 3,527 (5,968) (796)

Net income 42,295 73,120 9,759 118,148 223,189 29,787

Earnings per share:

Basic 0.42 0.58 0.08 1.31 1.94 0.26

Diluted 0.42 0.57 0.08 1.31 1.87 0.25

Earnings per ADS:

Basic 0.85 1.17 0.16 2.62 3.88 0.52

Diluted 0.85 1.14 0.15 2.62 3.75 0.50

Simcere Pharmaceutical Group
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
7. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... accounted for 3.5 percent of high school athletes...st study to examine rare injuries and conditions o... eye injuries, dental injuries, neck and cervical ...ay result in high morbidity, costly surgeries and ...ball was associated with the highest rate of rare ...
(Date:12/2/2008)...stCall/ -- United American Healthcare,Corporation...hensive healthcare,management services to a manag...d that its Board of Directors has approved a share...epurchase up to $1.0 million of its outstanding,c...ompany,s common shares to be purchased in the,ope...
(Date:12/2/2008)...Newswire/ -- Today, advocates for teen,dating vio... together at Liz,Claiborne Inc. to launch ,MADE, ...g Abuse. Ann and Chris Burke, educators and parent...usive ex-boyfriend, are joining efforts with Liz,...al coalition that will,consist of parents, teache...
(Date:12/2/2008)...e-FirstCall/ -- UnitedHealth Group,(NYSE: UNH )...o become "health,care heroes" by learning about c...t and implementing the programs in their communiti...ning, health literacy initiative,designed to enco...youth,leaders, to create and implement local hand...
Breaking Medicine News(10 mins):Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2
...ple who undergo a lot of mental strain contracting... correlated simultaneous changes // in blood pres...hat is known about the brain and its links to stre...rom research on animals. But the new study on huma...
...n (ED) can be cured effective only by penile prost...ts with prosthesis // by researchers from St. Pete...they found that 89% of the study patients were abl...le prosthesis. Erectile dysfunction or Impotence ...
...sychiatric care in the UK are being detained in ex...t, owing to a massive shortage // of NHS beds. T... perpetual crisis management, with patients being ... to clear ward space, according to inspectors from...
... cause of death and liver transplant in the wester...is incidence is five times more when compared to H...of Saskatchewan's Vaccine and Infectious Disease O...ine candidate to treat hepatitis C infection. Thi...
Other Medicine News:Health News:NHS faces mental health crisis; 'risky' patients sent home 2
(Date:12/1/2008)...ewswire/ -- Roche announced today that a,comparat...ceived pain and,discomfort associated with blood ...nitoring systems and lancing devices were deemed l...rall, the ACCU-CHEK Aviva and ACCU-CHEK Compact,P...CHEK Multiclix, ACCU-CHEK,Softclix and ACCU-CHEK ...
(Date:12/1/2008)... the best policy , , ROCHESTER, Minn., Dec...yo Clinic finds the use of the drug therapy etaner...an acute inflammation of the liver caused by exces...udy are published in the December issue of Gastro... , VIDEO ALERT: Additional audio and video r...
(Date:12/1/2008)...led for Tuesday, December 9 at 11:00 am ET to Disc...UTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-Fi... SNSS ), a biopharmaceutical company focused on ...ogy therapeutics, today announced new data from it...AML) will be presented during the 50th American So...
(Date:11/30/2008)... 1 Older adults who exe... and a greater number of small blood vessels in th...the annual meeting of the Radiological Society of ...cted at the University of North Carolina ( UNC) ...s of older adults who exercise to brain scans of t...
Breaking Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Ultrafast lasers give CU Boulder researchers a snapshot of electrons in action 8771 1Ultrafast lasers give CU Boulder researchers a snapshot of electrons in action 8771 2Vigorous activity protects against breast cancer 28359 1Vigorous activity protects against breast cancer 28359 2Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real Time PCR Platform 28356 1Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real Time PCR Platform 28356 2Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real Time PCR Platform 28356 3Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 1Schering Plough to Appeal Jury Decision in Missouri Reimbursement Case 28353 2
... System simplifies the process of separating prote... able to run four gels at a time, maximizing throu...hput, the 120 mini-vertical runs up to four 8 x 7 ... has a modular design. The basic system comes comp...
E-Gel® 96 and E-Gel® 48 gels run in the specially designed E-Base™ electrophoresis bases, which combine the base and power supply in one device. , The mother E-Base™ power supply
...orm is designed with a spring-loaded mechanism to ...l cassettes stay firmly in place during robotic lo...ing from one gel to the next without having to mak...dition, the E-Holder™ Platform allows you to...
The Classic Series gel tanks come with turn and cast gel trays or gasketed gel trays, making gel pouring as simple as possible. , Designed to give you total felxibility in your application. Avaialbl
Medicine Products: